Target Ferritin and TSAT in CKD Stage 5 on Dialysis
For hemodialysis patients with CKD stage 5, maintain a transferrin saturation (TSAT) ≥20% and serum ferritin ≥200 ng/mL to support adequate erythropoiesis and optimize anemia management.
Iron Status Targets for Hemodialysis Patients
The target iron parameters differ between hemodialysis and non-dialysis CKD patients due to ongoing blood losses and ESA requirements:
Minimum Thresholds
- TSAT: ≥20% 1, 2, 3
- Ferritin: ≥200 ng/mL for hemodialysis patients 2, 4
- For non-dialysis CKD patients, the lower ferritin threshold is ≥100 ng/mL 1, 2
Upper Safety Limits
The 2006 KDOQI guidelines 2 specifically raised the ferritin target for hemodialysis patients to 200 ng/mL (compared to 100 ng/mL in the 2001 guidelines) based on evidence showing substantial efficacy of IV iron at ferritin levels below 200 ng/mL in this population.
Rationale for These Targets
Why TSAT ≥20%?
This threshold indicates sufficient iron availability for erythropoiesis. Below 20%, the likelihood of functional or absolute iron deficiency increases substantially, limiting red blood cell production even with adequate ESA therapy 1.
Why Ferritin ≥200 ng/mL for Hemodialysis?
Hemodialysis patients face unique challenges:
- Repetitive dialyzer-related blood losses requiring higher iron stores 1
- ESA-stimulated erythropoiesis creating increased iron demand 1
- Oral iron inadequacy - most hemodialysis patients cannot maintain adequate iron status with oral supplementation alone 1
The higher ferritin target (200 vs 100 ng/mL) reflects these ongoing losses and the need for IV iron maintenance 2, 4.
Important Caveats and Clinical Considerations
Functional Iron Deficiency
Many patients remain functionally iron deficient despite meeting minimum thresholds (TSAT ≥20%, ferritin ≥200 ng/mL). Additional iron should be given when hemoglobin remains <11 g/dL or ESA doses are higher than expected, provided this doesn't chronically maintain TSAT >50% or ferritin >800 ng/mL 1.
Ferritin as an Acute Phase Reactant
Ferritin levels can be falsely elevated during inflammation or infection 1. In such cases, TSAT becomes more reliable for assessing true iron availability. Consider clinical context when interpreting elevated ferritin values.
Upper Limit Controversy
While the 2012 KDIGO guidelines 3 suggest considering iron therapy when ferritin is ≤500 ng/mL and TSAT ≤30%, long-term safety of maintaining ferritin >500 ng/mL remains unproven 5. The more conservative approach of keeping ferritin <500-800 ng/mL is prudent given decades of safe experience at these levels 1.
Monitoring Frequency
- Check TSAT and ferritin at least every 3 months once target hemoglobin is achieved 1
- Monitor monthly during ESA initiation or dose adjustments 1
- More frequent monitoring is needed after IV iron courses or with blood loss 3
Practical Management Algorithm
If TSAT <20% and/or ferritin <200 ng/mL: Administer IV iron (typically 100-125 mg weekly for 8-10 doses) 1
If TSAT ≥20% and ferritin ≥200 ng/mL but hemoglobin <11 g/dL: Consider trial of 1.0 g IV iron over 8-10 weeks to assess response 1
If TSAT >50% and/or ferritin >800 ng/mL: Withhold IV iron for up to 3 months, then recheck parameters before resuming at reduced dose 1
Maintenance phase: Most hemodialysis patients require 25-125 mg IV iron weekly to maintain targets 1
Key Differences from Non-Dialysis CKD
Non-dialysis CKD patients (stages 3-5 not on dialysis) have a lower ferritin threshold of ≥100 ng/mL 2, 4, as they lack the repetitive blood losses of hemodialysis and may respond adequately to oral iron supplementation in some cases 3, 1.